ANG Lifesciences India Share Price
32.73-1.72 (-4.99%)
+3.18% past 1 Year
Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.
Price Analysis
About
Stock Analysis (SWOT)
QVT
Peer Stocks
1 week
1 month
1 year
Name
SUNPHARMA-ANSE
DIVISLAB-ANSE
TORNTPHARM-ANSE
ZYDUSLIFE-ANSE
LAURUSLABS-ANSE
CIPLA-ANSE
DRREDDY-ANSE
MANKIND-ANSE
AUROPHARMA-ANSE
LUPIN-ANSE
ANG-TNSE
ANG Lifesciences India Share Price
32.73-1.72 (-4.99%)
+3.18% past 1 Year
Financial overview
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
CAGR%
Sales
Profits
Returns
ROE
| 10Y | 5Y | 3Y | TTM |
|---|---|---|---|
| - | - | -36% | -36% |
| - | - | - | -22% |
| - | -40% | -22% | 9% |
| 4% | 4% | -10% | -18% |
Peer Comparison
Symbol
SUNPHARMA-A
DIVISLAB-A
TORNTPHARM-A
ZYDUSLIFE-A
LAURUSLABS-A
CIPLA-A
DRREDDY-A
MANKIND-A
AUROPHARMA-A
LUPIN-A
ANG-T
| Price | M.Cap (₹) | PE Ratio | EPS (₹) | EV/EBITDA | Annual PAT |
|---|---|---|---|---|---|
| 1,764.4 | ₹419620 Cr | 34.69 | 12.07 | 62.82 | ₹11479 Cr |
| 9,002 | ₹239714 Cr | 81.95 | 34.04 | 128.41 | ₹2568 Cr |
| 4,622.95 | ₹174741 Cr | 80.12 | 16.72 | 97.06 | ₹2163 Cr |
| 1,144.7 | ₹112119 Cr | 24.84 | 9.42 | 62.53 | ₹5040 Cr |
| 2,021.7 | ₹110008 Cr | 100.61 | 6.8 | 29.25 | ₹889 Cr |
| 1,330.15 | ₹106061 Cr | 31.47 | 9.77 | 57.87 | ₹3879 Cr |
| 1,222.6 | ₹101339 Cr | 31.45 | 5.32 | 63.99 | ₹4196 Cr |
| 2,344.35 | ₹96244 Cr | 47.12 | 13.75 | 71.08 | ₹1913 Cr |
| 1,676.4 | ₹95590 Cr | 25.75 | 17.95 | 96.84 | ₹3505 Cr |
| 1,969.65 | ₹89391 Cr | 16.17 | 30.95 | 154.35 | ₹5333 Cr |
| 32.73 | ₹45 Cr | — | -3.25 | -5.38 | -₹11 Cr |
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Dec 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ₹15 Cr | ₹24 Cr | ₹19 Cr | ₹26 Cr | ₹25 Cr | ₹17 Cr | ₹25 Cr | ₹33 Cr | ₹18 Cr | ₹38 Cr | ₹19 Cr | ₹33 Cr | ₹56 Cr | ₹39 Cr | ₹47 Cr | ₹60 Cr | ₹74 Cr | ₹95 Cr | ₹50 Cr | ₹89 Cr | ₹120 Cr | ₹32 Cr |
| ₹11 L | ₹17 L | ₹16 L | ₹12 L | ₹9 L | ₹65 L | -₹27 L | ₹35 L | ₹1 Cr | ₹19 L | -₹3 L | ₹22 L | ₹32 L | ₹9 Cr | ₹24 L | ₹16 L | ₹9 L | ₹57 L | ₹16 L | ₹10 L | ₹8 L | ₹4 L |
| ₹15 Cr | ₹24 Cr | ₹19 Cr | ₹26 Cr | ₹25 Cr | ₹17 Cr | ₹24 Cr | ₹33 Cr | ₹20 Cr | ₹38 Cr | ₹19 Cr | ₹33 Cr | ₹57 Cr | ₹49 Cr | ₹47 Cr | ₹60 Cr | ₹74 Cr | ₹96 Cr | ₹50 Cr | ₹90 Cr | ₹120 Cr | ₹32 Cr |
| ₹19 Cr | ₹23 Cr | ₹23 Cr | ₹27 Cr | ₹25 Cr | ₹19 Cr | ₹29 Cr | ₹32 Cr | ₹22 Cr | ₹37 Cr | ₹22 Cr | ₹34 Cr | ₹52 Cr | ₹53 Cr | ₹46 Cr | ₹52 Cr | ₹64 Cr | ₹85 Cr | ₹46 Cr | ₹71 Cr | ₹91 Cr | ₹31 Cr |
| -₹2 Cr | ₹3 Cr | -₹3 Cr | ₹20 L | ₹73 L | -₹5 L | -₹2 Cr | ₹3 Cr | -₹42 L | ₹4 Cr | -₹2 Cr | ₹2 Cr | ₹7 Cr | -₹1 Cr | ₹3 Cr | ₹10 Cr | ₹12 Cr | ₹13 Cr | ₹5 Cr | ₹20 Cr | ₹30 Cr | ₹2 Cr |
| ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹4 Cr | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹4 Cr | ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹93 L |
| -₹6 Cr | -₹1 Cr | -₹6 Cr | -₹3 Cr | -₹3 Cr | -₹4 Cr | -₹6 Cr | -₹1 Cr | -₹4 Cr | -₹4 Cr | -₹6 Cr | -₹3 Cr | ₹2 Cr | -₹6 Cr | -₹3 Cr | ₹4 Cr | ₹7 Cr | ₹7 Cr | ₹2 Cr | ₹17 Cr | ₹28 Cr | ₹46 L |
| -₹4 Cr | -₹1 Cr | -₹5 Cr | -₹3 Cr | -₹2 Cr | -₹2 Cr | -₹5 Cr | -₹2 Cr | -₹3 Cr | -₹4 Cr | -₹6 Cr | -₹2 Cr | ₹2 Cr | -₹5 Cr | -₹2 Cr | ₹3 Cr | ₹3 Cr | ₹5 Cr | ₹1 Cr | ₹13 Cr | ₹20 Cr | ₹22 L |
Balance Sheet
Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Trade Payables
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| — | — | — | — |
| ₹13 Cr | ₹13 Cr | ₹13 Cr | ₹10 Cr |
| ₹51 Cr | ₹63 Cr | ₹73 Cr | ₹73 Cr |
| ₹51 Cr | ₹63 Cr | ₹73 Cr | ₹73 Cr |
| ₹64 Cr | ₹76 Cr | ₹86 Cr | ₹84 Cr |
| ₹8 Cr | ₹13 Cr | ₹17 Cr | ₹21 Cr |
| ₹10 Cr | ₹1 Cr | ₹1 Cr | ₹84 L |
| -₹6 Cr | -₹3 Cr | -₹3 Cr | -₹4 Cr |
| ₹2 Cr | ₹3 Cr | ₹6 Cr | ₹15 Cr |
| ₹0 | ₹2 Cr | ₹2 Cr | ₹2 Cr |
| ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
| ₹16 Cr | ₹17 Cr | ₹25 Cr | ₹37 Cr |
| — | — | — | — |
| ₹66 Cr | ₹66 Cr | ₹68 Cr | ₹71 Cr |
| ₹21 Cr | ₹24 Cr | ₹31 Cr | ₹30 Cr |
| ₹56 Cr | ₹50 Cr | ₹45 Cr | ₹47 Cr |
| ₹28 L | ₹4 Cr | ₹18 Cr | ₹19 Cr |
| ₹143 Cr | ₹145 Cr | ₹162 Cr | ₹166 Cr |
| ₹223 Cr | ₹238 Cr | ₹274 Cr | ₹287 Cr |
| ₹4 Cr | ₹16 Cr | ₹17 Cr | ₹20 Cr |
| ₹80 Cr | ₹69 Cr | ₹68 Cr | ₹77 Cr |
| — | — | — | — |
| ₹126 Cr | ₹121 Cr | ₹147 Cr | ₹142 Cr |
| ₹69 Cr | ₹62 Cr | ₹59 Cr | ₹49 Cr |
| ₹57 Cr | ₹58 Cr | ₹88 Cr | ₹93 Cr |
| ₹3 L | ₹3 L | ₹3 L | ₹3 L |
| ₹3 L | ₹3 L | ₹3 L | ₹3 L |
| ₹66 L | ₹62 L | ₹52 L | ₹41 L |
| ₹0 | ₹0 | ₹0 | ₹88 L |
| ₹58 Cr | ₹59 Cr | ₹89 Cr | ₹94 Cr |
| — | — | — | — |
| ₹54 Cr | ₹48 Cr | ₹48 Cr | ₹37 Cr |
| ₹67 Cr | ₹73 Cr | ₹83 Cr | ₹102 Cr |
| ₹4 Cr | ₹6 Cr | ₹6 Cr | ₹7 Cr |
| ₹1 Cr | ₹1 Cr | ₹2 Cr | ₹1 Cr |
| ₹36 Cr | ₹46 Cr | ₹43 Cr | ₹46 Cr |
| ₹161 Cr | ₹173 Cr | ₹183 Cr | ₹193 Cr |
| ₹18 Cr | ₹29 Cr | ₹21 Cr | ₹27 Cr |
| ₹223 Cr | ₹238 Cr | ₹274 Cr | ₹287 Cr |
| ₹49 | ₹58 | ₹66 | ₹81 |
| ₹49 | ₹58 | ₹66 | ₹65 |
Cash Flow
Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| -₹16 Cr | -₹11 Cr | ₹3 Cr | ₹54 Cr |
| ₹13 Cr | ₹20 Cr | ₹21 Cr | ₹17 Cr |
| ₹6 Cr | -₹5 Cr | ₹7 Cr | -₹45 Cr |
| ₹4 Cr | ₹4 Cr | ₹30 Cr | ₹25 Cr |
| -₹26 L | -₹9 Cr | ₹26 Cr | ₹25 Cr |
| -₹2 Cr | ₹20 Cr | -₹9 Cr | -₹44 Cr |
| ₹2 Cr | -₹10 Cr | -₹17 Cr | ₹20 Cr |
| -₹16 L | -₹57,000 | -₹2 L | ₹23 L |
| ₹32 L | ₹32 L | ₹35 L | ₹11 L |
| ₹16 L | ₹32 L | ₹32 L | ₹35 L |
Fundamental Ratios
Consolidated
Standalone
No results found
ANG Lifesciences India Share Price
32.73-1.72 (-4.99%)
+3.18% past 1 Year
Technical meters
Oscillators
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 3
Bearish signals: 6 out of 9 oscillators
RSI
36.48Sell
STOCH %K
15.76Buy
MACD Level(12,26)
-0.23Sell
Ultimate Oscillator
31.32Sell
Aroon Oscillator
48.00Sell
BOP
-1.00Sell
CCI
-138.16Buy
Williams %R
-84.24Buy
Momentum
-6.76Sell
Moving averages
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 2
Bearish signals: 7 out of 9 moving averages
EMA 9
35.44Sell
SMA 9
35.97Sell
EMA 21
36.29Sell
SMA 21
37.73Sell
EMA 50
35.20Sell
SMA 50
34.06Sell
EMA 200
31.52Buy
SMA 200
29.49Buy
WMA 20
36.96Sell
Pivot
Pivot
Classic
Resistance 5
46.48
Resistance 4
43.20
Resistance 3
39.92
Resistance 2
36.64
Resistance 1
35.54
Pivot
33.36
Support 1
32.26
Support 2
30.08
Support 3
26.80
Support 4
23.52
Support 5
20.24
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
ANG Lifesciences India Share Price
32.73-1.72 (-4.99%)
+3.18% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly
Name
Promoters
FII
DII - Others
DII - MFs
Retail & Others
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| 70.60% | 70.60% | 70.60% | 70.60% | 70.60% | 70.60% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 29.40% | 29.40% | 29.40% | 29.40% | 29.40% | 29.40% |
Bulk & block deals
Name
Chauhan Trishul Jitusinh
Chauhan Trishul Jitusinh
Alpha Leon Enterprises Llp
Alpha Leon Enterprises Llp
Ways Vinimay Private Limited
Ways Vinimay Private Limited
Ways Vinimay Private Limited
Sanjay Popatlal Jain
Leena Sachin Shetty
Sundeep Arjun Karna Huf
| Deal Date | Action | Deal Value | Deal Price | Qty Traded | Deal Type | %Stake Traded | Exchange |
|---|---|---|---|---|---|---|---|
| 03 Jan 2024 | Purchase | 69.37 L | ₹81.93 | 84.67 K | Bulk | 0.648423 | BSE |
| 03 Jan 2024 | Sell | 70.47 L | ₹83.23 | 84.67 K | Bulk | 0.648423 | BSE |
| 12 Nov 2021 | Purchase | 3.57 Cr | ₹621 | 57.48 K | Bulk | 0.44021 | BSE |
| 12 Nov 2021 | Sell | 74.05 L | ₹677.77 | 10.93 K | Bulk | 0.083671 | BSE |
| 30 Sep 2021 | Sell | 1.12 Cr | ₹349.55 | 32 K | Bulk | 0.245055 | BSE |
| 05 Aug 2021 | Sell | 1.12 Cr | ₹370.05 | 30.40 K | Bulk | 0.232802 | BSE |
| 02 Aug 2021 | Sell | 1.70 Cr | ₹331.25 | 51.20 K | Bulk | 0.392088 | BSE |
| 28 Jul 2021 | Purchase | 1.54 Cr | ₹282.64 | 54.40 K | Bulk | 0.416593 | BSE |
| 14 Jul 2021 | Purchase | 64.61 L | ₹183.55 | 35.20 K | Bulk | 0.26956 | BSE |
| 02 Jul 2021 | Sell | 52.43 L | ₹109.22 | 48 K | Bulk | 0.367582 | BSE |
Insider trading & SAST
Client name
Rajesh Gupta
Rajesh Gupta
Rajesh Gupta
| Reported on | Client category | Action | %Stake traded | Holding % post deal | Deal value | Deal price | Qty traded | Deal period | Deal mode | Post transaction holding | Insider/SAST | Regulation type | Security type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 16 Jun 2022 | Promoter | Acquisition | 0.01 | 70.95 | 0 | — | 1 K | 13 Jun 2022 | Market | 73,55,630 | SAST | 29(2) | — |
| 04 Mar 2022 | Promoter | Acquisition | 0.03 | 70.95 | 0 | — | 3.20 K | 02 Mar 2022 | Market | 73,54,630 | SAST | 29(2) | — |
| 01 Mar 2022 | Promoter | Acquisition | 0.02 | 70.91 | 0 | — | 2 K | 24 Feb 2022 | Market | 73,51,430 | SAST | 29(2) | — |
ANG Lifesciences India Share Price
32.73-1.72 (-4.99%)
+3.18% past 1 Year
ANG Lifesciences India is ISO-9001:2008 certified and has the modern & sophisticated plant equipments technique and manpower. The planning and construction of plant has been done to conform to the
Corporate Actions
Date
Type
Details
Company details
ANG Lifesciences India Share Price
32.73-1.72 (-4.99%)
+3.18% past 1 Year
Corporate filings & documents
Announcements
Annual reports
Concalls & investor presentations
ANG Lifesciences India Share Price
32.73-1.72 (-4.99%)
+3.18% past 1 Year
News
ANG Lifesciences reports Profit after tax of 1.10 Crores, in the March 2026 quarter
Equity
ANG
ANG Lifesciences reports Profit after tax of Rs -4.24 Crores, in the December 2025 quarter
Equity
ANG
ANG Lifesciences India informs about confirmation certificate
Equity
ANG
ANG Lifesciences reports Profit after tax of Rs -80.10 Lakhs, in the September 2025 quarter
Equity
ANG
ANG Lifesciences - Quaterly Results
Equity
ANG
ANG Lifesciences reports Profit after tax of Rs -78.70 Lakhs, in the June 2025 quarter
Equity
ANG
ANG Lifesciences - Quaterly Results
Equity
ANG
ANG Lifesciences India informs about compliance certificate
Equity
ANG
ANG Lifesciences India informs about trading window closure
Equity
ANG
ANG Lifesciences reports Profit after tax of Rs -1.94 Crores, in the March 2025 quarter
Equity
ANG
ANG Lifesciences informs about not applicability of large corporate entity
Equity
ANG
ANG Lifesciences reports Profit after tax of Rs -4.56 Crores, in the December 2024 quarter
Equity
ANG
ANG Lifesciences - Quaterly Results
Equity
ANG
ANG Lifesciences reports Profit after tax of Rs -1.07 Crores, in the September 2024 quarter
Equity
ANG
ANG Lifesciences India informs about trading window closure
Equity
ANG
ANG Lifesciences reports Profit after tax of Rs -2.77 Crores, in the June 2024 quarter
Equity
ANG
ANG Lifesciences - Quaterly Results
Equity
ANG
ANG Lifesciences India informs about closure of trading window
Equity
ANG
ANG Lifesciences reports Profit after tax of Rs -3.60 Crores, in the March 2024 quarter
Equity
ANG
ANG Lifesciences - Quaterly Results
Equity
ANG